Comment on "Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study".
APA
Wang H, Xu X, et al. (2026). Comment on "Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study".. Hepatology international. https://doi.org/10.1007/s12072-025-10970-9
MLA
Wang H, et al.. "Comment on "Efficacy and safety of atezolizumab and bevacizumab with or without TACE as first-line therapy for unresectable HCC: a multicenter cohort study".." Hepatology international, 2026.
PMID
41483107
같은 제1저자의 인용 많은 논문 (5)
- Safety and Efficacy of Selective Neurectomy of the Gastrocnemius Muscle for Calf Reduction in 300 Cases.
- Application of machine learning algorithms and establishment of a web calculator in predicting distant metastasis of T2-T4 gastric cancer.
- Preoperative frailty prevalence and risk factors in oral cancer patients: a meta-analysis.
- Lipidomics and single-cell transcriptomics uncover aberrant lipid metabolism in metaplasia lesions during gastric carcinogenesis.
- Disparities in use and outcomes of robotic surgery for gastric cancer: An evaluation of a large national cohort.